参考图片
Expression of CD11b on bone-marrow myeloid cells. C57BL/6 bone-marrow leukocytes were stained with either PE-Cy™7 Rat IgG2b, κ isotype control (Cat. No. 552849, left panel) or PE-Cy™7 Rat Anti-CD11b (Cat. No. 552850/561098; right panel). Please note that the population of cells having the lowest SSC (erythroid and lymphoid cells) show little expression of CD11b, while cells with moderate-to-high SSC (myeloid cells) are almost uniformly CD11b positive (right panel). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
Expression of CD11b on bone-marrow myeloid cells. C57BL/6 bone-marrow leukocytes were stained with either PE-Cy™7 Rat IgG2b, κ isotype control (Cat. No. 552849, left panel) or PE-Cy™7 Rat Anti-CD11b (Cat. No. 552850/561098; right panel). Please note that the population of cells having the lowest SSC (erythroid and lymphoid cells) show little expression of CD11b, while cells with moderate-to-high SSC (myeloid cells) are almost uniformly CD11b positive (right panel). Flow cytometry was performed on a BD FACSCalibur™ flow cytometry system.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9108.html